Literature DB >> 29565667

Undiagnosed HIV and HCV Infection in a New York City Emergency Department, 2015.

Lucia V Torian1, Uriel R Felsen1, Qiang Xia1, Fabienne Laraque1, Eric J Rude1, Herbert Rose1, Adam Cole1, Angelica Bocour1, Gary J Williams1, Robert F Bridgforth1, Lisa A Forgione1, Howard Doo1, Sarah L Braunstein1, Demetre C Daskalakis1, Barry S Zingman1.   

Abstract

OBJECTIVES: To measure undiagnosed HIV and HCV in a New York City emergency department (ED).
METHODS: We conducted a blinded cross-sectional serosurvey with remnant serum from specimens originally drawn for clinical indications in the ED. Serum was deduplicated and matched to (1) the hospital's electronic medical record and (2) the New York City HIV and HCV surveillance registries for evidence of previous diagnosis before being deidentified and tested for HIV and HCV.
RESULTS: The overall prevalence of HIV was 5.0% (250/4990; 95% confidence interval [CI] = 4.4%, 5.7%); the prevalence of undiagnosed HIV was 0.2% (12/4990; 95% CI = 0.1%, 0.4%); and the proportion of undiagnosed HIV was 4.8% (12/250; 95% CI = 2.5%, 8.2%). The overall prevalence of HCV (HCV RNA ≥ 15 international units per milliliter) was 3.9% (196/4989; 95% CI = 2.8%, 5.1%); the prevalence of undiagnosed HCV was 0.8% (38/4989; 95% CI = 0.3%, 1.3%); and the proportion of undiagnosed HCV was 19.2% (38/196; 95% CI = 11.4%, 27.0%).
CONCLUSIONS: Undiagnosed HCV was more prevalent than undiagnosed HIV in this population, suggesting that aggressive testing initiatives similar to those directed toward HIV should be mounted to improve HCV diagnosis.

Entities:  

Mesh:

Year:  2018        PMID: 29565667      PMCID: PMC5888049          DOI: 10.2105/AJPH.2018.304321

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  25 in total

Review 1.  HIV transmission rates from persons living with HIV who are aware and unaware of their infection.

Authors:  H Irene Hall; David R Holtgrave; Catherine Maulsby
Journal:  AIDS       Date:  2012-04-24       Impact factor: 4.177

2.  HIV Care Continuum for HIV-Infected Emergency Department Patients in an Inner-City Academic Emergency Department.

Authors:  Yu-Hsiang Hsieh; Gabor D Kelen; Oliver Laeyendecker; Chadd K Kraus; Thomas C Quinn; Richard E Rothman
Journal:  Ann Emerg Med       Date:  2015-02-23       Impact factor: 5.721

3.  Prevalence of Diagnosed and Undiagnosed Hepatitis C in a Midwestern Urban Emergency Department.

Authors:  Michael S Lyons; Vidhya A Kunnathur; Susan D Rouster; Kimberly W Hart; Matthew I Sperling; Carl J Fichtenbaum; Kenneth E Sherman
Journal:  Clin Infect Dis       Date:  2016-02-21       Impact factor: 9.079

4.  HIV testing in U.S. emergency departments: at the crossroads.

Authors:  Yu-Hsiang Hsieh; Lee Wilbur; Richard E Rothman
Journal:  Acad Emerg Med       Date:  2012-07-20       Impact factor: 3.451

5.  Assessing the impact of a community-wide HIV testing scale-up initiative in a major urban epidemic.

Authors:  Julie E Myers; Sarah L Braunstein; Colin W Shepard; Blayne H Cutler; Andrea R Mantsios; Monica M Sweeney; Benjamin W Tsoi
Journal:  J Acquir Immune Defic Syndr       Date:  2012-09-01       Impact factor: 3.731

Review 6.  Hepatitis C virus infection in USA: an estimate of true prevalence.

Authors:  Eric Chak; Andrew H Talal; Kenneth E Sherman; Eugene R Schiff; Sammy Saab
Journal:  Liver Int       Date:  2011-03-16       Impact factor: 5.828

7.  Unrecognized chronic hepatitis C virus infection among baby boomers in the emergency department.

Authors:  James W Galbraith; Ricardo A Franco; John P Donnelly; Joel B Rodgers; Jordan M Morgan; Andres F Viles; Edgar T Overton; Michael S Saag; Henry E Wang
Journal:  Hepatology       Date:  2015-01-28       Impact factor: 17.425

8.  Ledipasvir and sofosbuvir for 8 or 12 weeks for chronic HCV without cirrhosis.

Authors:  Kris V Kowdley; Stuart C Gordon; K Rajender Reddy; Lorenzo Rossaro; David E Bernstein; Eric Lawitz; Mitchell L Shiffman; Eugene Schiff; Reem Ghalib; Michael Ryan; Vinod Rustgi; Mario Chojkier; Robert Herring; Adrian M Di Bisceglie; Paul J Pockros; G Mani Subramanian; Di An; Evguenia Svarovskaia; Robert H Hyland; Phillip S Pang; William T Symonds; John G McHutchison; Andrew J Muir; David Pound; Michael W Fried
Journal:  N Engl J Med       Date:  2014-04-10       Impact factor: 91.245

9.  Identification of acute HIV infection using fourth-generation testing in an opt-out emergency department screening program.

Authors:  Kara I Geren; Frank Lovecchio; Jason Knight; Robert Fromm; Eric Moore; Cheri Tomlinson; André Valdez; Dan Hobohm; J Stephan Stapczynski
Journal:  Ann Emerg Med       Date:  2014-06-23       Impact factor: 5.721

10.  Current and future therapies for hepatitis C virus infection.

Authors:  Marc G Ghany; T Jake Liang
Journal:  N Engl J Med       Date:  2013-08-15       Impact factor: 91.245

View more
  11 in total

1.  An expanded HIV screening strategy in the Emergency Department fails to identify most patients with undiagnosed infection: insights from a blinded serosurvey.

Authors:  Uriel R Felsen; Lucia V Torian; Donna C Futterman; Stephen Stafford; Qiang Xia; David Allan; David Esses; Chinazo O Cunningham; Jeffrey M Weiss; Barry S Zingman
Journal:  AIDS Care       Date:  2019-05-30

2.  Association of human immunodeficiency virus and hepatitis C virus infection with long-term outcomes post-ST segment elevation myocardial infarction in a disadvantaged urban community.

Authors:  Sanyog G Shitole; Mark H Kuniholm; David B Hanna; Thomas Boucher; Angel Y Peng; Cecilia Berardi; Tina Shah; Anna E Bortnick; Panagiota Christia; James Scheuer; Jorge R Kizer
Journal:  Atherosclerosis       Date:  2020-08-27       Impact factor: 5.162

3.  Computer-Based Substance Use Reporting and Acceptance of HIV Testing Among Emergency Department Patients.

Authors:  I D Aronson; C M Cleland; S Rajan; L A Marsch; T C Bania
Journal:  AIDS Behav       Date:  2020-02

4.  Attitudes, practices and perceived barriers to hepatitis C screening among medical residents at a large urban academic medical center.

Authors:  Daniel Winetsky; Jason Zucker; Caroline Carnevale; Deborah Theodore; Matthew Scherer; Fereshteh Sani; Katherine Elkington; Alwyn Cohall; Magdalena E Sobieszczyk; Peter Gordon; Susan Olender
Journal:  J Viral Hepat       Date:  2019-08-09       Impact factor: 3.728

5.  Individualized Provider Feedback Increased HIV and HCV Screening and Identification in a New York City Emergency Department.

Authors:  Jason Zucker; Lawrence Purpura; Fereshteh Sani; Simian Huang; Aaron Schluger; Kenneth Ruperto; Jacek Slowkowski; Susan Olender; Matt Scherer; Delivette Castor; Peter Gordon
Journal:  AIDS Patient Care STDS       Date:  2022-03       Impact factor: 5.944

6.  A Digital Case-Finding Algorithm for Diagnosed but Untreated Hepatitis C: A Tool for Increasing Linkage to Treatment and Cure.

Authors:  Brooke Wyatt; Ponni V Perumalswami; Anna Mageras; Mark Miller; Alyson Harty; Ning Ma; Chip A Bowman; Francina Collado; Jihae Jeon; Lismeiry Paulino; Amreen Dinani; Douglas Dieterich; Li Li; Maxence Vandromme; Andrea D Branch
Journal:  Hepatology       Date:  2021-12       Impact factor: 17.298

7.  Toward a human-centered use of technology: a stakeholder analysis of harm reduction and CBO staff.

Authors:  Ian David Aronson; Alex S Bennett; Robert Freeman
Journal:  Harm Reduct J       Date:  2020-10-19

8.  Hepatitis C virus infection and risk factors among patients and health-care workers of Ain Shams University hospitals, Cairo, Egypt.

Authors:  Wagida A Anwar; Maha El Gaafary; Samia A Girgis; Mona Rafik; Wafaa M Hussein; Dalia Sos; Isis M Mossad; Arnaud Fontanet; Laura Temime
Journal:  PLoS One       Date:  2021-02-08       Impact factor: 3.240

Review 9.  Innovations in Hepatitis C Screening and Treatment.

Authors:  Arpan A Patel; Aileen Bui; Eian Prohl; Debika Bhattacharya; Su Wang; Andrea D Branch; Ponni V Perumalswami
Journal:  Hepatol Commun       Date:  2020-12-07

10.  Escape from planned obsolescence: Hepatitis C, the cirrhotic liver, and clonal expansions.

Authors:  Andrea D Branch
Journal:  J Exp Med       Date:  2020-03-02       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.